Pancreatic Cancer Research

ResearcherGunma UniversityActive in the last 2 years

Kei Hagiwara

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5102125236. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 4 papers · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 11

  1. Achievement of the Ideal Outcome After Pancreatectomy for Pancreatic Ductal Adenocarcinoma Is Associated With Earlier Initiation and Higher Completion Rates of… Co-author DOI 10.1002/ags3.70270↗
  2. Impact of Preoperative Weight Loss on Prognosis in Patients with Pancreatic Cancer. Co-author DOI 10.3390/biomedicines13071703↗
  3. Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Co-author DOI 10.1111/cas.16087↗
  4. Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer. Co-author DOI 10.1002/ags3.12671↗
  5. High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer. Co-author DOI 10.1007/s10147-023-02342-w↗
  6. D-Dimer Could Be a Surrogate Postoperative Prognostic Marker of Resectable Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001537↗
  7. Long-term survival of two patients with pancreatic cancer after resection of liver and lung oligometastases: a case report. Co-author DOI 10.1186/s40792-020-01029-y↗
  8. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreati… Co-author DOI 10.1245/s10434-019-07708-x↗
  9. ASO Author Reflections: Clinical Significance of Large Tenascin C Splice Variants and Annexin A2 for Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-08009-z↗
  10. Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts. Co-author DOI 10.1111/cas.13847↗
  11. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer. Co-author DOI 10.21873/anticanres.12307↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ken Shirabe · 11 shared papers, 2018–2026 · strength 1.66
  2. Kenichiro Araki · 10 shared papers, 2018–2026 · strength 1.47
  3. Mariko Tsukagoshi · 9 shared papers, 2018–2026 · strength 1.36
  4. Norifumi Harimoto · 9 shared papers, 2018–2024 · strength 1.14
  5. Akira Watanabe · 8 shared papers, 2018–2024 · strength 0.95
  6. Takamichi Igarashi · 6 shared papers, 2018–2026 · strength 0.86
  7. Norihiro Ishii · 7 shared papers, 2018–2024 · strength 0.84
  8. Takahiro Yamanaka · 6 shared papers, 2018–2024 · strength 0.66
  9. Takehiko Yokobori · 5 shared papers, 2018–2024 · strength 0.56
  10. Ryosuke Fukushima · 2 shared papers, 2025–2026 · strength 0.52
  11. Atsushi Masamune · 2 shared papers, 2019–2024 · strength 0.26
  12. Takaomi Seki · 1 shared paper, 2025 · strength 0.23
  13. Kiyoaki Ito · 1 shared paper, 2024 · strength 0.18
  14. Chingunjav Batbayar · 1 shared paper, 2023 · strength 0.15
  15. Hiroyuki Kuwano · 2 shared papers, 2018–2019 · strength 0.14
  16. Kazunobu Suzuki · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.